Skip to main content

VCI Global Completes Sagtec Global Limited’s Nasdaq IPO, Earning US$5.7 Million in Advisory Revenue

Sagtec Global Limited’s IPO Marks V Capital Consultancy Group’s Third Successful Nasdaq Listing Within a Year KUALA LUMPUR, Malaysia, March 07, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”) is pleased to announce the successful initial public offering (IPO) of its client, Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec”), facilitated through its capital market advisory arm, V Capital Consultancy Group Limited (“VCCG”, or the “Company”). Leveraging its expertise, VCCG guided Sagtec through the entire IPO process, resulting in its trading debut on March 7, 2025. The IPO raised US$7 million, resulting in a post-listing valuation of over US$50 million for Sagtec. As Sagtec’s IPO consultant, VCCG provided strategic guidance and collaborated with key professionals throughout the listing process. The IPO generated...

Continue reading

BW Offshore: New awards under Long-Term Incentive Programme

New awards under Long-Term Incentive Programme The Board of Directors of BW Offshore Limited (“BWO” or the “Company”) has approved new awards under the Long-Term Incentive Programme (LTIP) adopted in 2024. The programme is a combination of Share Options and Restricted Share Unit (RSUs), aimed to align the interests of the participating employees with those of the Company’s shareholders. The programme is discretionary, and participants are invited on an annual basis. The total number of options awarded under the LTIP for 2025 is 800,000 where each option will give the holder the right to acquire one BW Offshore share. A total of 6 BW Offshore employees have been invited to participate in the Share Option Programme. The strike price of the options is calculated based on the volume weighted average share price...

Continue reading

Toll Brothers Opens Charterfield Landing in Collegeville, Pennsylvania

COLLEGEVILLE, Pa., March 07, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced that Charterfield Landing is now open for sale in Collegeville, Pennsylvania. This new community showcases an exclusive selection of expansive home sites with thoughtfully designed open-concept floor plans featuring side-entry garages and basements, as well as sophisticated options for personalization. The Sales Center and model home are now open at 4037 MacCormack Way in Collegeville. “Charterfield Landing provides home buyers with the opportunity to experience luxury living in a peaceful and picturesque setting,” said John Dean, Division President of Toll Brothers in Pennsylvania. “The community’s desirable blend of comfort and convenience, along with its proximity to upscale shopping...

Continue reading

Kaldalón hf.: Financial Calendar 2025

Kaldalón hf. will publish its financial results and trading updates as per the following schedule:Annual General Meeting April 3, 2025Q1 2025 Trading update May 19, 2025H1 2025 Half-year Results August 21, 2025Q3 2025 Trading update November 17, 2025Management statement 2025 February 12, 2026Approved statements 2025 March 4, 2026Annual General Meeting 2025 March 26, 2026All financial information will be released after market close. Please note that the dates are subject to change. For further information, please contact:Jón Þór Gunnarsson, CEO of Kaldalón hf.Email: jon.gunnarsson@kaldalon.is

Continue reading

Ferrari N.v.: Completion of the Seventh Tranche of the Multi-Year Share Repurchase Program

Maranello (Italy), March 7, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that, following the accelerated bookbuild offering made by Exor N.V. on February 26, 2025, the Company participated in the offering by purchasing No. 666,666 common shares for a total consideration of 299,999,700 Euro (the “Transaction”). The Transaction constituted the seventh tranche (the “Seventh Tranche”) of the multi-year share buyback program of approximately Euro 2.0 billion announced during our 2022 Capital Market Day (the ”Program”) and it settled on March 3, 2025. As of March 6, 2025, following the completion of the Seventh Tranche, the Company held in treasury No. 15,785,877 common shares equal to 8.73% of the total issued share capital including the common shares and the special voting shares, net of shares assigned under...

Continue reading

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT). An audio webcast of the fireside chat will also be available to investors and the general public and can be accessed in the Events Section of Alvotech’s Investor Portal. After the event, a recording will also be available for 90 days. About AlvotechAlvotech is...

Continue reading

Freddie Mac Announces $290 million Non-Performing Loan Sale

Includes one Extended Timeline Pool Offering Targeting Smaller Investors MCLEAN, Va., March 07, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announced today it will offer approximately $290 million in non-performing loans (NPL) for sale via auction. The NPLs being offered consist of seasoned, deeply delinquent residential first lien whole loans held in Freddie Mac’s mortgage-related investments portfolio. The NPLs are currently serviced by Select Portfolio Servicing Inc., Newrez LLC, d/b/a Shellpoint Mortgage Servicing or Nationstar Mortgage LLC, d/b/a Rushmore Servicing. The NPLs are being marketed via four pools: three Standard Pool Offerings (SPO®) and one Extended Timeline Pool Offering (EXPO®), which targets participation by smaller investors, including non-profits and Minority, Women, Disabled, LGBTQ+, Veteran or Service-Disabled...

Continue reading

Stargaze Taps Film Producer and Mogul Elie Samaha for Strategic Advisor Role

Owner of TCL Chinese Theatre and Dolby Theatre to Provide Strategic Guidance, Expanding Access to Premier Industry Venues and Relationships LOS ANGELES, March 07, 2025 (GLOBE NEWSWIRE) — Stargaze Entertainment Group Inc. (“Stargaze” or the “Company”) (OTC: STGZ), a content creation and social platform designed to redefine talent discovery, has appointed renowned film producer and entertainment mogul Elie Samaha to its Advisory Board. This addition is set to strengthen Stargaze’s industry influence and expand opportunities for emerging talent. As a key public figure in Hollywood, Samaha’s ownership of two of the most iconic venues in entertainment provides Stargaze with unprecedented access to industry-defining spaces, including the TCL Chinese Theatre, a historic movie palace on the Hollywood Walk of Fame, and the Dolby Theatre,...

Continue reading

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT). An audio webcast of the fireside chat will also be available to investors and the general public and can be accessed in the Events Section of Alvotech’s Investor Portal. After the event, a recording will also be available for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely...

Continue reading

Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent

Hamilton, March 07, 2025 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for a patent (application #17/466,142) relating to the composition of Bentrio®, a nasal spray developed and commercialized by its affiliate Altamira Medica AG (“Medica”) for preventing or treating allergic rhinitis. The claims are directed to the key ingredients and composition of Bentrio’s proprietary formulation. The patent, upon issuance, will have an initial priority date of September 8, 2020, and is expected to provide key intellectual property protection for Bentrio in the USA, the world’s largest market for “over the counter (OTC)” products for allergic rhinitis relief and treatment. “We are very pleased to have achieved this...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.